Hepatitis A vaccination policy in Catalonia (Spain)
References (141)
Update on viral hepatitis in children
Pediatr Clinic of North Am
(1996)Hepatitis A
Lancet
(1998)- et al.
Epidemiology of hepatitis A: seroepidemiology and risk groups in the USA
Vaccine
(1992) - et al.
Decrease of hepatitis A and B virus infections in the population of Okinawa, Japan
J Infect
(1991) - et al.
Safety profile and immunogenicity of an inactivated vaccine derived from an attenuated strain of hepatitis A
Vaccine
(1992) - et al.
Development of the formalin-inactivated hepatitis A vaccine, VAQTA, from the live attenuated virus strain CR326F
J Hepatol
(1993) - et al.
Good immunogenicity of GBM strain inactivated hepatitis A vaccine in healthy male adults
Vaccine
(1995) - et al.
Inactivated hepatitis A vaccine: long-term antibody persistence
Vaccine
(1997) - et al.
Hepatitis A vaccine: persistence of antibodies 5 years after the first vaccination
Vaccine
(1997) - et al.
Cost-effectiveness analysis of hepatitis A prevention in travellers
Vaccine
(1992)
Risk of hepatitis A in travellers
Vaccine
(1992)
A community-wide outbreak of hepatitis A: risk factors for infection among homosexual and bisexual men
Am J Med
(1995)
Hepatitis A virus
Hepatitis A virus
Type A viral hepatitis
Type A viral hepatitis: epidemiology, diagnosis and prevention
Clinical Chemistry
(1997)
Hepatitis A revisited
Ann Intern Med
(1986)
Global impact of hepatitis A virus infection. Changing patterns
Anonymous. Hepatitis A: a vaccine at last
Lancet
(1992)
Hepatitis A vaccine
N Engl J Med
(1992)
Will Hepatitis A become a vaccine preventable disease?
Ann Intern Med
(1995)
Hepatitis A ¿una enfermedad erradicable?
Med Clín (Barc)
(1992)
The value of immunization against hepatitis A
Infect Agent Dis
(1994)
CDC Prevention of hepatitis A through active or passive immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR
(1996)
Vaccines to prevent viral hepatitis
N Engl J Med
(1997)
American Academy of Pediatrics. Committee on Infectious Diseases. Prevention of Hepatitis A. Guidelines for use of hepatitis A vaccine and immune globulins
Pediatrics
(1996)
Informe de la Asociación Española para el Estudio del Hígado. Indicaciones y prescripción de la vacuna de la hepatitis A en España
Med Clín (Barc)
(1998)
Cambio en el patrón epidemiológico de la hepatitis A en Cataluña (España)
Med Clín (Barc)
(1992)
Cambios en la seroepidemiología de la infección por el virus de la hepatitis A en Cataluña en el período 1989-1996. Implicaciones para una nueva estrategia vacunal
Med Clín (Barc)
(1999)
Prevalencia de los anticuerpos contra el virus de la hepatits A en la población general.Estudio comparativo 1971-1985
Med Clín (Barc)
(1987)
The prevalence of antibodies to hepatitis A antigen in various parts of the world: a pilot study
Am J Epidemiol
(1977)
Hepatitis A virus infections: new insights on seroepidemiologic studies
J Infect Dis
(1978)
Seroepidemiology of hepatitis A in the United States
J Infect Dis
(1995)
The changing epidemiology of hepatitis A infection in Scandinavia
Scand J Infect Dis
(1978)
Hepatitis A: changing prevalence and possible vaccines
Br Med J
(1991)
Eficiencia de la detección prevacunal de anti-VHA en los programas de vacunación antihepatitis A
Med Clín (Barc)
(1995)
Epidemiología de las hepatitis virales
Enf Infec Microbiol Clin
(1995)
Hepatitis A virus
Inactivated candidate vaccine for hepatitis A
Prog Med Virol
(1990)
Hepatitis A virus: current concepts of the molecular virology, im-munobiology and approaches to vaccine development
Rev Med Virol
(1992)
Clinical trial of a lyophilized inactivated hepatitis A candidate vaccine in healthy adult volunteers
Vaccine
(1992)
A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children
N Engl J Med
(1992)
Immunogenicity, safety and tolerability of varying doses and regimens of inactivated hepatitis A virus vaccine in Navajo children
Pediatr Infect Dis J
(1994)
Protection against hepatitis A by an inactivated vaccine
JAMA
(1994)
Inactivated hepatitis A vaccines
JAMA
(1994)
Clinical experience with an inactivated hepatitis A vaccine
J Infect Dis
(1995)
Inactivated hepatitis A vaccine: reactogenicity, immunogenicity and long-term antibody persistence
J Med Virol
(1994)
Planificación de los programas de vacunaciones
Vacuna antihepatitis A
Is travel prophilaxis wortwhile? Economic appraisal of prophilactic measures against malaria, hepatitis A and typhoid in travellers
Br Med J
(1994)
Cited by (0)
Copyright © 2000 Elsevier España, S.L. All rights reserved.